C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

Cited by (1,014)

Items 601–700 of 1,014

1. Folate and Vitamin B6 Rapidly Normalize Endothelial Dysfunction In Children With Type 1 Diabetes Mellitus
   Karen E. MacKenzie, Esko J. Wiltshire, Roger J. Gent, Craig Hirte, Lino Piotto, Jennifer Couper · 2006 · PEDIATRICS
2. Previous Gestational Diabetes Mellitus and Markers of Cardiovascular Risk
   Nikolaos Vrachnis, Areti Augoulea, Zoi Iliodromiti, Irene V. Lambrinoudaki, Stavros Sifakis, George K. Creatsas · 2012 · International Journal of Endocrinology
3. Coronary Spasm is Associated With Chronic Low-Grade Inflammation
   Teruhiko Itoh, Yuji Mizuno, Eisaku Harada, Michihiro Yoshimura, Hisao Ogawa, Hirofumi Yasue · 2007 · Circulation Journal
4. Human Genome Screen to Identify the Genetic Basis of the Anti-inflammatory Effects of Boswellia in Microvascular Endothelial Cells
   Sashwati Roy, Savita Khanna, Hiral Anil Shah, Cameron L. Rink, Christina Phillips, Harry G. Preuss, Gottumukkala Venkata Subbaraju, Trimurtulu Golakoti, Krishnaraju Venkata Alluri, Manashi Bagchi et al. · 2005 · DNA and Cell Biology
5. Prediction of Myocardial Infarction by N-Terminal-Pro-B-Type Natriuretic Peptide, C-Reactive Protein, and Renin in Subjects With Cerebrovascular Disease
   Duncan John Campbell, Mark Woodward, John Philip Chalmers, Samuel A. Colman, Alicia Josephine Jenkins, Bruce E. Kemp, Bruce Charles Neal, Anushka A Patel, Stephen W MacMahon · 2005 · Circulation
6. Ancestry as a Determinant of Mean Population C-Reactive Protein Values
   Tina Shah, Paul J. Newcombe, Liam L Smeeth, Juliet Addo, Juan Pablo Casas, John C. Whittaker, Michelle A. Miller, Lorna Tinworth, Steve Jeffery, Pasquale Strazzullo et al. · 2010 · Circulation Cardiovascular Genetics
7. The role of inflammation in cardiovascular diseases: the predictive value of neutrophil–lymphocyte ratio as a marker in peripheral arterial disease
   Feliciano Chanana Paquissi · 2016 · Therapeutics and Clinical Risk Management
8. Drug-induced vascular injury—a quest for biomarkers
   Expert Working Group on Drug-Induced Vascular Injury · 2004 · Toxicology and Applied Pharmacology
9. POOR NUTRITIONAL STATUS AND INFLAMMATION: C‐Reactive Protein and End‐Stage Renal Disease
   Eduardo Lacson, Nathan W. Levin · 2004 · Seminars in Dialysis
10. Relationship Between C-Reactive Protein and Atherosclerotic Risk Factors and Oxidative Stress Markers Among Young Persons 10–18 Years Old
    Roya Kelishadi, Mohsen Sharifi, Alireza Khosravi, Khosrow Adeli · 2007 · Clinical Chemistry
11. Time-Restricted Eating to Improve Cardiovascular Health
    Kelsey Gabel, Sofia Cienfuegos, Faiza Kalam, Mark Ezpeleta, Krista A Varady · 2021 · Current Atherosclerosis Reports
12. C-reactive protein impairs angiogenic functions and decreases the secretion of arteriogenic chemo-cytokines in human endothelial progenitor cells
    Wonhee Suh, Koung Li Kim, Jin‐Ho Choi, Young‐Sam Lee, Jae-Young Lee, Jeong‐Min Kim, Hyung‐Suk Jang, In‐Soon Shin, Jung‐Sun Lee, Jonghoe Byun et al. · 2004 · Biochemical and Biophysical Research Communications
13. Elevated serum high-sensitivity C-reactive protein levels in fibromyalgia syndrome patients correlate with body mass index, interleukin-6, interleukin-8, erythrocyte sedimentation rate
    Yangming Xiao, Wanda L Haynes, Joel Edmund Michalek, Irwin Jon Russell · 2012 · Rheumatology International
14. Supplementation with orange and blackcurrant juice, but not vitamin E, improves inflammatory markers in patients with peripheral arterial disease
    Dalgård, Christine, Nielsen, Flemming, Morrow, Jason D., Enghusen-Poulsen, Henrik, Jonung, Torbjörn, Hørder, Mogens, de Maat, Moniek P. M. · 2008 · British Journal Of Nutrition
15. Dietary inflammatory potential and risk of mortality in metabolically healthy and unhealthy phenotypes among overweight and obese adults
    Yong‐Moon Park, Moon Kyung Choi, Seongsu Lee, Nitin Shivappa, Kyungdo Han, Susan E. Steck, James R. Hébert, Anwar T. Merchant, Dale P. Sandler · 2018 · Clinical Nutrition
16. Adaptive self-regulation, subjective well-being, and physical health: The importance of goal adjustment capacities
    Carsten Wrosch, Michael F. Scheier · 2019 · Advances in motivation science
17. Immunology of ischemic vascular disease: plaque to attack
    John M. Hallenbeck, Göran K. Hansson, Kyra J. Becker · 2005 · Trends in Immunology
18. Seventeen year risk of all-cause and cause-specific mortality associated with C-reactive protein, fibrinogen and leukocyte count in men and women: the EPIC-Norfolk study
    Sara Ahmadi‐Abhari, Robert Luben, Nicholas J. Wareham, Kay‐Tee Khaw · 2013 · European Journal of Epidemiology
19. A Genetic Association Study of Serum Acute-Phase C-Reactive Protein Levels in Rheumatoid Arthritis: Implications for Clinical Interpretation
    Benjamin Rhodes, Marilyn E. Merriman, Andrew A. Harrison, Michael John Nissen, Malcolm Smith, Lisa K. Stamp, Sophia E Steer, Tony Raymond Merriman, Timothy James Vyse · 2010 · PLoS Medicine
20. Assessing inflammatory status in cardiovascular disease
    Dimitris Tousoulis, C. Antoniades, Christodoulos Stefanadis · 2007 · Heart
21. Co‐localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction
    Yasunari Hoshiba, Kinta Hatakeyama, T. TANABE, Yujiro Asada, Shinya Goto · 2005 · Journal of Thrombosis and Haemostasis
22. Osteoprotegerin and Soluble Receptor Activator of Nuclear Factor-κB Ligand and Risk for Coronary Events
    Anne Grete Semb, Thor Ueland, Pål Aukrust, Nicholas J. Wareham, Robert Luben, Lars Lysgaard Gullestad, John J.P. Kastelein, Kay‐Tee Khaw, S. Matthijs Boekholdt · 2009 · Arteriosclerosis Thrombosis and Vascular Biology
23. C-Reactive Protein as a Risk Predictor
    Michelle Asha Albert, Paul M. Ridker · 2006 · Circulation
24. Metabolic Syndrome, Inflammation, and Risk of Symptomatic Peripheral Artery Disease in Women
    David Conen, Kathryn M. Rexrode, Mark A. Creager, Paul M. Ridker, Aruna D. Pradhan · 2009 · Circulation
25. Nanomedicine for the prevention, treatment and imaging of atherosclerosis
    Costas T. Psarros, Regent Lee, Marios Margaritis, Charalambos A. Antoniades · 2012 · Nanomedicine Nanotechnology Biology and Medicine
26. Hemostatic Factors, Inflammatory Markers, and Progressive Peripheral Atherosclerosis
    Ioanna Tzoulaki, Gordon D. Murray, Jacqueline F. Price, Felicity B. Smith, Amanda Jane Lee, Ann Rumley, Gordon D O Lowe, F. Gerald R. Fowkes · 2005 · American Journal of Epidemiology
27. Effects of ezetimibe coadministered with simvastatin on C-reactive protein in a large cohort of hypercholesterolemic patients
    Philip T. Sager, Rachel Capece, Leslie Lipka, John T. Strony, Bo Yang, Ramachandran Suresh, Yale Mitchel, Enrico P. Veltri · 2004 · Atherosclerosis
28. Comparative analysis of red cell distribution width and high sensitivity C-reactive protein for coronary heart disease mortality prediction in multi-ethnic population: Findings from the 1999–2004 NHANES
    Vikas Veeranna, SANDIP K. ZALAWADIYA, Sidakpal Panaich, Kushang V. Patel, Luis Afonso · 2013 · International Journal of Cardiology
29. Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology
    Охота Сергей Денисович, Мельников Иван Сергеевич, Yuliya Avtaeva, Sergey G. Kozlov, Габбасов Зуфар Ахнафович · 2020 · International Journal of Molecular Sciences
30. Relationship of Serum Inflammatory Biomarkers With Plaque Inflammation Assessed by FDG PET/CT
    Raphaël Duivenvoorden, Venkatesh Mani, Mark Woodward, David G. Kallend, Gabriela Suchánková, Valentı́n Fuster, James H F Rudd, Ahmed A Tawakol, Michael E. Farkouh, Zahi Adel Fayad · 2013 · JACC. Cardiovascular imaging
31. Cardiovascular co-morbidity in early rheumatoid arthritis
    Holly John, George D. Kitas, Tracey E. Toms, Nicola J. Goodson · 2009 · Best Practice & Research Clinical Rheumatology
32. Fetal programming of atherosclerosis: Possible role of the mitochondria
    Line Leduc, Emile H. Levy, Maurice Bouity-Voubou, EDGARD E. DELVIN · 2010 · European Journal of Obstetrics & Gynecology and Reproductive Biology
33. Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk
    Altan Onat, Günay Can, Gülay Hergenç · 2008 · Metabolism
34. Global inflammation predicts cardiovascular risk in women: A report from the Women's Ischemia Syndrome Evaluation (WISE) study
    Kip, Kevin E., Marroquin, Oscar C., Shaw, Leslee J., Arant, Christopher B., Wessel, Timothy R., Olson, Marian B., Johnson, B. Delia, Mulukutla, Suresh, Sopko, George, Merz, C. Noel Bairey et al. · 2005 · American Heart Journal
35. Parental separation in childhood and adult inflammation: The importance of material and psychosocial pathways
    Lacey, Rebecca E., Kumari, Meena, McMunn, Anne · 2013 · Psychoneuroendocrinology
36. Associations of 25(OH) and 1,25(OH)2Vitamin D With Long-Term Outcomes in Stable Renal Transplant Recipients
    Charlotte A. te Velde‐Keyzer, Ineke J. Riphagen, Michel M. Joosten, Gerjan J Navis, Anneke C. Muller Kobold, Ido P. Kema, Stephan J. L. Bakker, Martin H. de Borst · 2014 · The Journal of Clinical Endocrinology & Metabolism
37. High-Sensitivity C-Reactive Protein Is Within Normal Levels at the Very Onset of First ST-Segment Elevation Acute Myocardial Infarction in 41% of Cases
    Nicole A. Cristell, Domenico Cianflone, Alessandro Durante, Enrico Ammirati, Diego Vanuzzo, Michela Banfi, Giliola Calori, Azeem Latib, Filippo Crea, Giancarlo Marenzi et al. · 2011 · Journal of the American College of Cardiology
38. C-Reactive Protein, Diastolic Dysfunction, and Risk of Heart Failure in Patients with Coronary Disease: Heart and Soul Study
    Eric S. Williams, Sanjiv Jayendra Shah, Sadia Ali, Bee Ya Na, Nelson B. Schiller, Mary A. Whooley · 2007 · European Journal of Heart Failure
39. Elevated C-reactive protein is associated with severe periodic leg movements of sleep in patients with restless legs syndrome
    Lynn Marie Trotti, David B. Rye, Christine De Staercke, William Craig Hooper, Arshed Ali Quyyumi, Donald L. Bliwise · 2012 · Brain Behavior and Immunity
40. From Vulnerable Plaque to Vulnerable Patient: The Search for Biomarkers of Plaque Destabilization
    Willem E. Hellings, Wouter Peeters, Frans L. Moll, Gerard Pasterkamp · 2007 · Trends in Cardiovascular Medicine
41. Proteína C reativa de alta sensibilidade como biomarcador de risco na doença coronária
    Doroteia Silva, António Pais de Lacerda · 2012 · Revista Portuguesa de Cardiologia
42. Impact of C-reactive protein and fibrinogen on cardiovascular prognosis in patients with stable angina pectoris: the AtheroGene study
    Jan‐Malte Sinning, Christoph Bickel, Claudia‐Martina Messow, Renate B. Schnabel, Edith Lubos, H.-J. Rupprecht, Christine Espinola–Klein, Karl Johannes Lackner, Laurence Tiret, Thomas F. Münzel et al. · 2006 · European Heart Journal
43. C-reactive protein exerts angiogenic effects on vascular endothelial cells and modulates associated signalling pathways and gene expression
    Marta Miguel Turu, MARK A. SLEVIN, Sabine Matou, David C. West, Cristina Rodrı́guez, Ana Luque, Marta Grau-Olivares, Lina Badimón, José Martínez‐González, Jerzy Krupiński · 2008 · BMC Cell Biology
44. C-reactive protein levels predict systolic heart failure and outcome in patients with first ST-elevation myocardial infarction treated with coronary angioplasty
    Christian Stumpf, Ahmed Sheriff, Stefan Zimmermann, Liane Schaefauer, Christian Schlundt, Dorette Raaz, Christoph D. Garlichs, Stephan S. Achenbach · 2017 · Archives of Medical Science
45. The effects of alpha-lipoic acid supplementation on inflammatory markers among patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials
    Maryam Akbari, Vahidreza Ostadmohammadi, Reza Tabrizi, Moein Mobini, Kamran Bagheri Lankarani, Mahmood Moosazadeh, Seyed Taghi Heydari, Maryam Chamani, Fariba Kolahdooz, Zatollah Asemi · 2018 · Nutrition & Metabolism
46. Prospects for Personalized Cardiovascular Medicine
    Geoffrey S. Ginsburg, Mark Donahue, Laura Kristin Newby · 2005 · Journal of the American College of Cardiology
47. Associations between blood volatile organic compounds, and changes in hematologic and biochemical profiles, in a population-based study
    Sabit Cakmak, Christie A. Cole, Chris Hebbern, Julie Andrade, Robert Dales · 2020 · Environment International
48. C-Reactive Protein Downregulates Endothelial NO Synthase and Attenuates Reendothelialization In Vivo in Mice
    Randall Schwartz, Sherri L. Osborne-Lawrence, Lisa Hahner, Linda L. Gibson, Andrew K. Gormley, Wanpen Vongpatanasin, Weifei Zhu, Ruth Ann Word, Divya Seetharam, Steven Black et al. · 2007 · Circulation Research
49. Direct comparison of dietary portfolio vs statin on C-reactive protein
    David J.A. Jenkins, Cyril W.C. Kendall, Augustine Marchie, Dorothea A. Faulkner, Andrea R. Josse, Julia MW Wong, Russell J. de Souza, A Emam, Tina L. Parker, T J Li et al. · 2005 · European Journal of Clinical Nutrition
50. Intra-individual variability of high-sensitivity C-reactive protein in Chinese general population
    Shouling Wu, Yun Li, Cheng Jin, Peng Yang, Dongqing Li, Hongfeng Li, Chong Shen · 2011 · International Journal of Cardiology
51. White Matter Lesions and Cognitive Performance: The Role of Cognitively Complex Leisure Activity
    Jane S. Saczynski, Marıá K. Jónsdóttir, Sigurdur Oli Sigurdsson, Guðný Eiríksdóttir, Pálmi V. Jónsson, M. Garcia, Ólafur Kjartansson, Mark A. van Buchem, Vilmundur G. Gudnason, Lenore J. Launer · 2008 · The Journals of Gerontology Series A
52. Nuts, inflammation and insulin resistance.
    Patricia Casas‐Agustench, Mònica Bulló, Jordi Salas‐Salvadó · 2010 · PubMed
53. Diet and Atherosclerosis
    Nevin S. Scrimshaw, M A Guzmán · 1964 · BMJ
54. Chronic Stress in Children and Adolescents: A Review of Biomarkers for Use in Pediatric Research
    Eileen M. Condon · 2018 · Biological Research For Nursing
55. PCSK9: A novel inflammation modulator in atherosclerosis?
    Zhi‐Han Tang, Tao‐Hua Li, Juan Peng, Jie Zheng, Tingting Li, Lushan Liu, Zhi‐Sheng Jiang, Xi‐Long Zheng · 2018 · Journal of Cellular Physiology
56. C‑reactive protein and cardiovascular disease: From animal studies to the clinic (Review)
    Yu Fu, Yi Wu, Enqi Liu · 2020 · Experimental and Therapeutic Medicine
57. Cardiac rehabilitation and exercise therapy in the elderly: Should we invest in the aged?
    Menezes Arthur R, Carl J. Lavie, V Milani Richard, Ross A Arena, S. Timothy · 2012 · 老年心脏病学杂志：英文版
58. Divergent Associations of Antecedent- and Response-Focused Emotion Regulation Strategies with Midlife Cardiovascular Disease Risk
    Allison A. Appleton, Eric B. Loucks, Stephen L. Buka, Laura Diane Kubzansky · 2014 · Annals of Behavioral Medicine
59. EN-RAGE
    Symen Ligthart, Sanaz Sedaghat, M. Arfan Ikram, Albert Hofman D, Oscar H. Franco, Abbas Dehghan · 2014 · Arteriosclerosis Thrombosis and Vascular Biology
60. T‐Helper Type 1 Bias in Healthy People Is Associated With Cytomegalovirus Serology and Atherosclerosis: The Multi‐Ethnic Study of Atherosclerosis
    Russell P. Tracy, Margaret F. Doyle, Nels C. Olson, Sally Ann Huber, Nancy S. Jenny, Reem M. Sallam, Bruce M. Psaty, Richard A. Kronmal · 2013 · Journal of the American Heart Association
61. Effects of CRP infusion on endothelial function and coagulation in normocholesterolemic and hypercholesterolemic subjects
    Radjesh J. Bisoendial, John J.P. Kastelein, Stephan L.M. Peters, Johannes H.M. Levels, Rakesh S. Birjmohun, Joris I. Rotmans, Daniel Hartman, Joost C.M. Meijers, Marcel M Levi, Erik S.G. Stroes · 2007 · Journal of Lipid Research
62. Injection of Adipose-Derived Stromal Cells in the Knee of Patients with Severe Osteoarthritis has a Systemic Effect and Promotes an Anti-Inflammatory Phenotype of Circulating Immune Cells
    Yves‐Marie Pers, Julie Quentin, Rosanna Feirreira, Francisco Espinoza, Naoill Abdellaoui, Nejla Erkilic, Maïlys Cren, Emilie Dufourcq-Lopez, Oliver Pullig, Ulrich Aran Nöth et al. · 2018 · Theranostics
63. Hip fracture and risk of acute myocardial infarction: A nationwide study
    Chia-Hung Chiang, Chia‐Jen Liu, Ping‐Jen Chen, Chin‐Chou Huang, Chien‐Yi Hsu, Zu-Yin Chen, Wan‐Leong Chan, Po‐Hsun Huang, Tzeng‐Ji Chen, Chia‐Min Chung et al. · 2012 · Journal of Bone and Mineral Research
64. C-Reactive Protein and Cardiovascular Diseases—Is it Ready for Primetime?
    Carl J. Lavie, Richard V. Milani, Anil Verma, James Henry O’Keefe · 2009 · The American Journal of the Medical Sciences
65. Infusion of Pharmaceutical-Grade Natural Human C-Reactive Protein Is Not Proinflammatory in Healthy Adult Human Volunteers
    Thirusha Lane, Nancy Wassef, Stephen Poole, Yogesh Mistry, Helen Jane Lachmann, Julian David Gillmore, Philip Nigel Hawkins, Mark B. Pepys · 2013 · Circulation Research
66. Red cell distribution width, inflammatory markers and cardiorespiratory fitness: Results from the National Health and Nutrition Examination Survey
    Shikhar Agarwal · 2012 · Indian Heart Journal
67. Cardiovascular Risk in Patients with Psoriatic Arthritis
    TRACY YANER ZHU, Edmund K. Li, Lai‐Shan Tam · 2012 · International Journal of Rheumatology
68. Fcγ Receptors and Ligands and Cardiovascular Disease
    Keiji Tanigaki, Nathan C. Sundgren, Amit Khera, Wanpen Vongpatanasin, Chieko Mineo, Philip W. Shaul · 2015 · Circulation Research
69. Markers of vascular inflammation are associated with the extent of atherosclerosis assessed as angiographic score and treadmill walking distances in patients with peripheral arterial occlusive disease
    M. Nylænde, A Kroese, E. Stranden, B. Morken, Gunnar Sandbæk, AK Lindahl, Harald Arnesen, Ingebjørg Seljeflot · 2006 · Vascular Medicine
70. Cardiovascular disease in systemic sclerosis - an emerging association?
    Gene‐Siew Ngian, Joanne Sahhar, Ian P. Wicks, Sharon Van Doornum · 2011 · Arthritis Research & Therapy
71. Associations of fibrinogen and C-reactive protein with prevalent and incident coronary heart disease are attenuated by adjustment for confounding factors
    George Davey Smith, Ann Rumley, Gordon D O Lowe, Shah B J Ebrahim, Debbie A. Lawlor · 2005 · Thrombosis and Haemostasis
72. Anti-depressant medication use and C-reactive protein: Results from two population-based studies
    Hamer, Mark, Batty, GD, Marmot, Michael G., Singh-Manoux, Archana, Kivimäki, Mika · 2011 · Brain, Behavior, and Immunity
73. Association of C‐reactive protein with body fat, diabetes and coronary artery disease in Asian Indians: The Chennai Urban Rural Epidemiology Study (CURES‐6)
    Viswanathan Mohan, R Deepa, K. Velmurugan, Gopal Premalatha · 2005 · Diabetic Medicine
74. Buyang Huanwu decoction ameliorates coronary heart disease with Qi deficiency and blood stasis syndrome by reducing CRP and CD40 in rats
    Hui Zhang, Wei‐Rong Wang, Rong Lin, Jiye Zhang, Qiaoli Ji, Qinqin Lin, Lina Yang · 2010 · Journal of Ethnopharmacology
75. Serum Levels of Mannose-Binding Lectin and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women
    Tymen T. Keller, Sander I. van Leuven, Marijn Clara‐Maud Meuwese, Nicholas J. Wareham, Robert Luben, Erik S.G. Stroes, C. Erik Hack, Marcel M Levi, Kay‐Tee Khaw, S. Matthijs Boekholdt · 2006 · Arteriosclerosis Thrombosis and Vascular Biology
76. Elevated Serum C-Reactive Protein Levels and Advanced Atherosclerosis in Youth
    Arthur W. Zieske, Russell P. Tracy, Clyde Alex McMahan, Edward E. Herderick, Satoki Homma, Gray T. Malcom, Henry C. McGill, Jack P. Strong · 2005 · Arteriosclerosis Thrombosis and Vascular Biology
77. Systemic lupus erythematosus in a multiethnic US Cohort (LUMINA). XXX: association between C-reactive protein (CRP) gene polymorphisms and vascular events
    Alexander J. Szalai, Graciela S. Alarcón, Jaime Calvo Alén, S Toloza, Mark A. McCrory, Jeffrey C. Edberg, Gerald McGwin, Holly M. Bastian, Barri J. Fessler, Luis M. Vilá et al. · 2005 · Lara D. Veeken
78. Inflammation, as Measured by the Erythrocyte Sedimentation Rate, Is an Independent Predictor for the Development of Heart Failure
    Ingelsson, Erik, Årnlöv, Johan, Sundström, Johan, Lind, Lars · 2005 · Journal of the American College of Cardiology
79. Leptin-Stimulated Endothelial Nitric-Oxide Synthase via an Adenosine 5′-Monophosphate-Activated Protein Kinase/Akt Signaling Pathway Is Attenuated by Interaction with C-Reactive Protein
    Maria Cristina Procopio, Francesco Andreozzi, Emanuela Laratta, Angela Cassese, Francesco Bèguinot, Franco Arturi, Marta Letizia Hribal, Francesco Perticone, Giorgio Sesti · 2009 · Endocrinology
80. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension
    Anoop Shankar, Jialiang Li, F. Javier Nieto, Barbara E.K. Klein, Ronald Klein · 2007 · American Heart Journal
81. C-Reactive Protein and Coronary Heart Disease: Predictive Test or Therapeutic Target?
    Aroon Dinesh Hingorani, Tina Shah, Juan Pablo Casas, Steve Eric Humphries, Philippa J. Talmud · 2008 · Clinical Chemistry
82. High intensity interval training reduces systemic inflammation in post-PCI patients
    Peter Scott Munk, Unni Mathilde Breland, Pål Aukrust, Thor Ueland, Jan Terje Kvaløy, Alf Inge Larsen · 2011 · European Journal of Cardiovascular Prevention & Rehabilitation
83. High density lipoproteins are modulators of protease activity: Implications in inflammation, complement activation, and atherothrombosis
    Scott M. Gordon, Alan Thomas Remaley · 2016 · Atherosclerosis
84. Is there more than C-reactive protein and fibrinogen?
    Marc B. I. Lobbes, Esther Lutgens, Sylvia Heeneman, Kitty B.J.M. Cleutjens, M. Eline Kooi, Jos M. A. van Engelshoven, Mat J.A.P. Daemen, Patricia Joan Nelemans · 2005 · Atherosclerosis
85. A comparison of the associations between seven hemostatic or inflammatory variables and coronary heart disease
    Mark Woodward, Ann Rumley, Paul I. Welsh, Stephen W MacMahon, Gordon D O Lowe · 2007 · Journal of Thrombosis and Haemostasis
86. C-Reactive Protein and Coronary Heart Disease: All Said—Is Not It?
    Frederik Strang, Heribert Schunkert · 2014 · Mediators of Inflammation
87. HMGB1 Is Associated with Atherosclerotic Plaque Composition and Burden in Patients with Stable Coronary Artery Disease
    Martin Andrassy, Hans Christian Volz, Alena Schüssler, Gitsios Gitsioudis, Nina Hofmann, Danai Laohachewin, Alexandra R. Wienbrandt, Ziya Kaya, Angelika Bierhaus, Evangelos Giannitsis et al. · 2012 · PLoS ONE
88. Sensitive and rapid quantification of C-reactive protein using quantum dot-labeled microplate immunoassay
    Yang Luo, Bo Zhang, Ming Chen, Tianlun Jiang, Daiyang Zhou, Junfu Huang, Weiling Fu · 2012 · Journal of Translational Medicine
89. C-reactive protein activates the nuclear factor-κB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells
    Yajing Liang, Kou‐Gi Shyu, Bo Wang, Ling‐Ping Lai · 2006 · Journal of Molecular and Cellular Cardiology
90. C-Reactive Protein in End-Stage Renal Disease: Are There Reasons to Measure It?
    Peter Stenvinkel, Bengt Lindholm · 2004 · Blood Purification
91. Associations of plasma pro‐inflammatory cytokines, fibrinogen, viscosity and C‐reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study
    Paul I. Welsh, Mark Woodward, Ann Rumley, Gordon D O Lowe · 2008 · British Journal of Haematology
92. Daily positive events and inflammation: Findings from the National Study of Daily Experiences
    Nancy L. Sin, Jennifer E. Graham‐Engeland, David M. Almeida · 2014 · Brain Behavior and Immunity
93. Measurement of Stiffness Index by Digital Volume Pulse Analysis Technique: Clinical Utility in Cardiovascular Disease Risk Stratification
    Ashan Gunarathne, Jeetesh V. Patel, Elizabeth Hughes, Gregory Y.H. Lip · 2008 · American Journal of Hypertension
94. Correlation of Oxidative Stress Parameters and Inflammatory Markers in Ischemic Stroke Patients
    Khouloud Chehaibi, Imen Trabelsi, Kacem Mahdouani, Mohamed Naceur Slimane · 2016 · Journal of Stroke and Cerebrovascular Diseases
95. Markers of Atherosclerosis: Part 1 – Serological Markers
    Miha Tibaut, Martin Čaprnda, Peter Kubatka, Andreja Sinkovič, Vanda Valentová, Slavomíra Filipová, Katarína Gazdíková, Ľudovít Gašpar, Ioana Monica Mozos, Emmanuel Eroume A Egom et al. · 2018 · Heart Lung and Circulation
96. Defining the Proinflammatory Phenotype Using High Sensitive C-Reactive Protein Levels as the Biomarker
    Sridevi Devaraj, Grant Edward O’Keefe, Ishwarlal Jialal · 2005 · The Journal of Clinical Endocrinology & Metabolism
97. Effects of Socioeconomic Position on Inflammatory and Hemostatic Markers: A Life-Course Analysis in the 1958 British Birth Cohort
    Tabassum, Faiza, Kumari, Meena, Rumley, Ann, Lowe, Gordon, Power, Chris, Strachan, David P. · 2008 · American Journal of Epidemiology
98. C-reactive protein in hypertension: clinical significance and predictive value
    Giuseppe Schillaci, Matteo Pirro · 2006 · Nutrition Metabolism and Cardiovascular Diseases
99. C-Reactive Protein Suppresses Insulin Signaling in Endothelial Cells: Role of Spleen Tyrosine Kinase
    Jin‐Wen Xu, Ikuo Morita, Katsumi Ikeda, Tomohiro Miki, Yukio Yamori · 2006 · Molecular Endocrinology
100. Reliability of Serum Biomarkers of Inflammation from Repeated Measures in Healthy Individuals
     Sandi L. Navarro, Theodore M. Brasky, Yvonne Schwarz, Xiaoling Song, C.Y. Wang, Alan R. Kristal, Mario Kratz, Emily White, Johanna W. Lampe · 2012 · Cancer Epidemiology Biomarkers & Prevention